Patent Trends across Oncolytic Virotherapy-Genetic Alert

Share this:
Published: 1 Apr 2016

This edition of the Genetic Alert depicts the current patent landscape and the new life sciences trends across oncolytic virotherapy. Analyst insights on oncolytics viral therapies are also included. The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: cancer therapeutics, oncolytic viral therapies, clinical trials, reovirus therapy, tumor, ovarian cancer, companion imaging


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..